Zaire Ebola vaccine candidates
Scope
Date
~
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Shareholder activism
Activist fund nominates director candidates for KT&G
A Singapore-based activist fund has stepped up pressure on the world’s fifth-largest tobacco maker KT&G Corp. to reform governance and boo...
Jan 19, 2023 (Gmt+09:00)
-
Energy
POSCO to enter palm oil refining market in Indonesia
POSCO International Co., a trading arm of South Korea’s steel giant POSCO Co., will build a palm oil refining plant in Indonesia to foray into...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's shingles vaccine obtains product approval from Malaysia
SK Bioscience Co. said on Monday that its shingles vaccine Sky Zoster has been given approval by Malaysia's National Pharmaceutical Regulatory Age...
Jan 09, 2023 (Gmt+09:00)
-
Leadership & Management
KT taps current CEO Ku as sole candidate for next chief
South Korea’s telecom giant KT Corp. has named current chief executive Ku Hyeon-mo the sole candidate for its next CEO during a board meeting ...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
HLB Therapeutics signs contract for COVID vaccine distribution rights
South Korea's pharmaceutical firm HLB Therapeutics Co. said on Monday that it has signed an agreement with the Korea Disease Control and Prevention ...
Dec 20, 2022 (Gmt+09:00)
-
Artificial intelligence
Syntekabio launches new drug development platform STB Cloud in US
Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug develo...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Artificial intelligence
LG Group think tank unveils breakthrough AI tech Exaone
LG AI Research, the artificial intelligence (AI) think tank of South Korea's LG Group, on Thursday unveiled Exaone, a gigantic AI technology that ra...
Dec 09, 2022 (Gmt+09:00)
-
Pension funds
NPS shortlists 6 candidates for chief investment officer opening
National Pension Service (NPS) of South Korea, the world’s third-largest pension fund managing 896.6 trillion won ($690.5 billion) as of end-S...
Dec 01, 2022 (Gmt+09:00)
-
Business & Politics
Tesla’s Musk names Korea among top candidate sites for Gigafactory
Tesla Inc. Chief Executive Elon Musk said on Wednesday that South Korea is among its top candidates to build in Asia another Gigafactory, the US ele...
Nov 23, 2022 (Gmt+09:00)
-
Pension funds
NPS narrows search for new CIO to two major candidates
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund managing 917.2 trillion won ($692 billion) in asset...
Nov 16, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience seeks WHO nod for prompt COVID vaccine sale
SK Bioscience Co., the biopharmaceutical unit of South Korea’s No. 2 conglomerate SK Group, sought approval from the World Health Organization...
Sep 08, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Lotte Card draws bid from Hana as key candidates back off
South Korea's Lotte Card Co. has drawn preliminary bids from Hana Financial Group, a leading banking group in the country, and two to three unidenti...
Sep 07, 2022 (Gmt+09:00)
-
Corporate investment
Korea to raise cash support on foreign investments in key sectors
South Korea plans to spend more cash on attracting foreign investments in high-tech and core supply chain industries as foreign direct investment to...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language -
Leadership & Management
Hyundai Mobis CEO runs for ISO president as first Korean candidate
Hyundai Mobis Co. CEO Cho Sung-hwan has registered as a candidate for the next presidential election of the International Organization for Standar...
Jun 21, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Samsung Elec. proposes global research for 6G frequencies
Samsung Electronics Co., South Korea’s tech behemoth, has put forward global research on 6G service frequencies as it aims to take the lead in...
May 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience becomes first to win domestic COVID-19 vaccine contract
SK Bioscience Co. said it reached a deal with Korea’s disease control agency to supply 10 million doses of the country’s first experimen...
Mar 22, 2022 (Gmt+09:00)
language -
Korean biotech startup signs license deal with US firm
South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...
Feb 17, 2022 (Gmt+09:00)
-
Earnings
SK Bioscience posts record earnings driven by COVID-19 vaccines
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, has posted record 2021 revenue and operating profit, boosted by contrac...
Feb 08, 2022 (Gmt+09:00)
-
IPOs
Viva Republica poised to become Korea’s fourth decacorn
Viva Republica Inc., the operator of fintech platform Toss, is revving up for a pre-IPO. When finalized, the company will become South Korea’s...
Feb 02, 2022 (Gmt+09:00)
-
Digital assets
Presidential candidates vow to legislate digital assets
Ahead of the 20th presidential election slated for March 9, candidates from both parties have vowed to legislate and systemize digital assets if ele...
Jan 20, 2022 (Gmt+09:00)
Latest News
- 1 Coupang bids for Korean luxury market dominance with Farfetch
- 2 Hyundai Rotem set to finalize $6 bn K2 tank order from Poland
- 3 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 4 Korea to allow non-profits to buy bad consumer loans
- 5 LG to drive future growth in emerging markets with battery prowess